Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
This study has been completed.
University of Texas Southwestern Medical Center
Information provided by (Responsible Party):
Heidi Jacobe, University of Texas Southwestern Medical Center
First received: December 18, 2008
Last updated: December 8, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2009|
|Primary Completion Date:||November 2009 (Final data collection date for primary outcome measure)|